Recruiting Neuropathy Studies in Flossmoor
EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy
This is a Platform Protocol to perform Phase II clinical trials in The Early Phase Pain Investigation Clinical Network (EPPIC-Net), under The Helping to End Addiction Long-termSM Initiative, or NIH HE...
EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA
The purpose of this study is to investigate the safety and efficacy of the current hard gelatin capsule formulation of NRD135S.E1 80 mg once daily in the treatment of PDPN when administered for 13 wee...
About Neuropathy Clinical Trials in Flossmoor
Neuropathy refers to damage or dysfunction of peripheral nerves, causing weakness, numbness, and pain, typically in the hands and feet. Diabetes is the most common cause, but it can also result from infections, injuries, and autoimmune conditions. Treatment focuses on managing the underlying cause and pain relief.
There are currently 2 neuropathy clinical trials recruiting participants in Flossmoor, IL. These studies are seeking a combined 244 participants. Research is being sponsored by James P. Rathmell, MD. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuropathy Clinical Trials in Flossmoor — FAQ
Are there neuropathy clinical trials in Flossmoor?
Yes, there are 2 neuropathy clinical trials currently recruiting in Flossmoor, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Flossmoor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Flossmoor research site will contact you about next steps.
Are clinical trials in Flossmoor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Flossmoor studies also compensate for your time and travel.
What neuropathy treatments are being tested?
The 2 active trials in Flossmoor are testing new therapies including novel drugs, biologics, and treatment approaches for neuropathy.
Data updated March 2, 2026 from ClinicalTrials.gov